markets·8d ago
Moderna Tops S&P 500 With 663% Gain as Cancer Vaccine Data Nears
Moderna shares are up about 663% in 2026, outrunning AI-linked names for the S&P 500's best performance, with full cancer vaccine data due October 24.
We use cookies for anonymous analytics and ad measurement to improve the site. Cookie policy.
Original coverage across the crypto market, updated daily.
Moderna shares are up about 663% in 2026, outrunning AI-linked names for the S&P 500's best performance, with full cancer vaccine data due October 24.